Pulmonx Corp
LUNG
$1.80-2.17%
End of day · as of Oct 12, 2026, 8:00 PM ET
Mkt cap
$111.92M
EV/Sales
0.88
P/E ratio
N/A
FY2025 Revenue
$90.50M
EPS (TTM)
$-1.15
Gross Margin (FY2025)
74.19%
Profit Margin (FY2025)
-59.67%
Beta
0.52
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
Latest reported LUNG revenue for 2025-12-31 was $90.5M. Net income was -$54.0M. Revenue was up 8.0% from 2024-12-31 to 2025-12-31. LUNG currently screens at market cap $111.9M.
Use this LUNG research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full LUNG income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Pulmonx Corp (LUNG) is a medical devices company in the Healthcare sector.
Latest cached Pulmonx Corp (LUNG) revenue for Dec 31, 2025 was $90.5M. Net income was -$54.0M. Statements: https://lician.com/financials/lung
Pulmonx Corp (LUNG) market capitalization is $111.9M on the latest cached snapshot.
Pulmonx Corp (LUNG) cached previous close $1.84; day range $1.80 – $1.81; volume 423,566. Session quote: https://lician.com/quote/lung
Pulmonx Corp (LUNG) latest cached earnings event is "LUNG earnings" on Jul 29, 2026. Earnings calendar: https://lician.com/earnings